Literature DB >> 15031715

Potent inhibitors of anthrax lethal factor from green tea.

Isabella Dell'Aica1, Massimo Donà, Fiorella Tonello, Alejandro Piris, Michèle Mock, Cesare Montecucco, Spiridione Garbisa.   

Abstract

The anthrax lethal factor (LF) has a major role in the development of anthrax. LF is delivered by the protective antigen (PA) inside the cell, where it exerts its metalloprotease activity on the N-terminus of MAPK-kinases. PA+LF are cytotoxic to macrophages in culture and kill the Fischer 344 rat when injected intravenously. We describe here the properties of some polyphenols contained in green tea as powerful inhibitors of LF metalloproteolytic activity, and how the main catechin of green tea, (-)epigallocatechin-3-gallate, prevents the LF-induced death of macrophages and Fischer 344 rats.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15031715      PMCID: PMC1299029          DOI: 10.1038/sj.embor.7400118

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  29 in total

1.  Tumor invasion: molecular shears blunted by green tea.

Authors:  S Garbisa; S Biggin; N Cavallarin; L Sartor; R Benelli; A Albini
Journal:  Nat Med       Date:  1999-11       Impact factor: 53.440

2.  Crystal structure of the anthrax lethal factor.

Authors:  A D Pannifer; T Y Wong; R Schwarzenbacher; M Renatus; C Petosa; J Bienkowska; D B Lacy; R J Collier; S Park; S H Leppla; P Hanna; R C Liddington
Journal:  Nature       Date:  2001-11-08       Impact factor: 49.962

3.  Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate.

Authors:  S Garbisa; L Sartor; S Biggin; B Salvato; R Benelli; A Albini
Journal:  Cancer       Date:  2001-02-15       Impact factor: 6.860

4.  Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor.

Authors:  G Vitale; L Bernardi; G Napolitani; M Mock; C Montecucco
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

5.  Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNgamma-induced release of NO and TNFalpha.

Authors:  R Pellizzari; C Guidi-Rontani; G Vitale; M Mock; C Montecucco
Journal:  FEBS Lett       Date:  1999-11-26       Impact factor: 4.124

6.  Effects of tea polyphenols on the invasion and matrix metalloproteinases activities of human fibrosarcoma HT1080 cells.

Authors:  M Maeda-Yamamoto; H Kawahara; N Tahara; K Tsuji; Y Hara; M Isemura
Journal:  J Agric Food Chem       Date:  1999-06       Impact factor: 5.279

7.  Matrix metalloproteinase inhibition by green tea catechins.

Authors:  M Demeule; M Brossard; M Pagé; D Gingras; R Béliveau
Journal:  Biochim Biophys Acta       Date:  2000-03-16

Review 8.  Structure and function of anthrax toxin.

Authors:  D B Lacy; R J Collier
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

9.  Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition.

Authors:  Jin Mo Park; Florian R Greten; Zhi-Wei Li; Michael Karin
Journal:  Science       Date:  2002-08-29       Impact factor: 47.728

10.  Screening inhibitors of anthrax lethal factor.

Authors:  Fiorella Tonello; Michela Seveso; Oriano Marin; Michèle Mock; Cesare Montecucco
Journal:  Nature       Date:  2002-07-25       Impact factor: 49.962

View more
  25 in total

Review 1.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

Review 2.  New developments in vaccines, inhibitors of anthrax toxins, and antibiotic therapeutics for Bacillus anthracis.

Authors:  J M Beierlein; A C Anderson
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

Review 3.  An overview of investigational toxin-directed therapies for the adjunctive management of Bacillus anthracis infection and sepsis.

Authors:  Lernik Ohanjanian; Kenneth E Remy; Yan Li; Xizhong Cui; Peter Q Eichacker
Journal:  Expert Opin Investig Drugs       Date:  2015-04-28       Impact factor: 6.206

4.  Identification of exosite-targeting inhibitors of anthrax lethal factor by high-throughput screening.

Authors:  Ludovic Bannwarth; Allison B Goldberg; Catherine Chen; Benjamin E Turk
Journal:  Chem Biol       Date:  2012-07-27

5.  Highly predictive support vector machine (SVM) models for anthrax toxin lethal factor (LF) inhibitors.

Authors:  Xia Zhang; Elizabeth Ambrose Amin
Journal:  J Mol Graph Model       Date:  2015-11-17       Impact factor: 2.518

6.  Small molecule inhibitors of anthrax lethal factor toxin.

Authors:  John D Williams; Atiyya R Khan; Steven C Cardinale; Michelle M Butler; Terry L Bowlin; Norton P Peet
Journal:  Bioorg Med Chem       Date:  2013-11-13       Impact factor: 3.641

7.  Identification of novel non-hydroxamate anthrax toxin lethal factor inhibitors by topomeric searching, docking and scoring, and in vitro screening.

Authors:  Ting-Lan Chiu; Jonathan Solberg; Satish Patil; Todd W Geders; Xia Zhang; Subhashree Rangarajan; Rawle Francis; Barry C Finzel; Michael A Walters; Derek J Hook; Elizabeth A Amin
Journal:  J Chem Inf Model       Date:  2009-12       Impact factor: 4.956

8.  Defensive strategies of Bacillus anthracis that promote a fatal disease.

Authors:  Jeremy Mogridge
Journal:  Drug Discov Today Dis Mech       Date:  2007

9.  Small-molecule inhibitors of lethal factor protease activity protect against anthrax infection.

Authors:  Mahtab Moayeri; Devorah Crown; Guan-Sheng Jiao; Seongjin Kim; Alan Johnson; Clinton Leysath; Stephen H Leppla
Journal:  Antimicrob Agents Chemother       Date:  2013-06-17       Impact factor: 5.191

10.  Use of a recombinant fluorescent substrate with cleavage sites for all botulinum neurotoxins in high-throughput screening of natural product extracts for inhibitors of serotypes A, B, and E.

Authors:  Harry B Hines; Alexander D Kim; Robert G Stafford; Shirin S Badie; Ernst E Brueggeman; David J Newman; James J Schmidt
Journal:  Appl Environ Microbiol       Date:  2007-12-14       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.